Vol 4, No 3 (2002)
Published online: 2002-11-08
Surgery for cardiac myxomas - a 20-year experience with transseptal approach
Chirurgia Polska 2002;4(3):125-131.
Abstract
Introduction: Cardiac myxomas are the most common primary cardiac tumours. The aim of this study was to assess the early and late results of surgical resection of cardiac myxomas with the use of transseptal technique.
Material and methods: Between 1981 and 2001, 23 patients (9 M/14 F) at mean age 44.7 ± 13.5 years (ranging from 21 to 74 years) were operated on. The myxomas were located in the left atrium in 18 cases (78.3%), in the right atrium in 3 patients (13.0%) and in both atria or in the right ventricle in single cases. All patients were operated on from median sternotomy in moderate hypothermia (26–28°C) with the use of cardiopulmonary bypass. Method of right atriotomy with transseptal incision was used. At the end of follow-up, clinical and echocardiographic examination (M + 2D + Doppler) were performed.
Results: One patient (4.3%) died in hospital. The mean follow-up of 5.8 ± 3.8 years (range from 3 months to 21 years) was completed by all patients. Two patients died during follow-up for noncardiac-related reasons. No tumour recurrences were observed. The cumulative survival rate calculated from the Kaplan-Meier curve was 85.3% after 5 years. At the end of follow-up all patients were in NYHA classes I or II.
Conclusions: Surgical resection of myxoma using transseptal approach is safe and effective with a low risk of recurrence.
Material and methods: Between 1981 and 2001, 23 patients (9 M/14 F) at mean age 44.7 ± 13.5 years (ranging from 21 to 74 years) were operated on. The myxomas were located in the left atrium in 18 cases (78.3%), in the right atrium in 3 patients (13.0%) and in both atria or in the right ventricle in single cases. All patients were operated on from median sternotomy in moderate hypothermia (26–28°C) with the use of cardiopulmonary bypass. Method of right atriotomy with transseptal incision was used. At the end of follow-up, clinical and echocardiographic examination (M + 2D + Doppler) were performed.
Results: One patient (4.3%) died in hospital. The mean follow-up of 5.8 ± 3.8 years (range from 3 months to 21 years) was completed by all patients. Two patients died during follow-up for noncardiac-related reasons. No tumour recurrences were observed. The cumulative survival rate calculated from the Kaplan-Meier curve was 85.3% after 5 years. At the end of follow-up all patients were in NYHA classes I or II.
Conclusions: Surgical resection of myxoma using transseptal approach is safe and effective with a low risk of recurrence.
Keywords: cardiac myxomasurgical treatmenttransseptal approach
